Literature DB >> 4091174

Olfactory neuroblastoma. A clinicopathologic study of 21 cases.

S E Mills, H F Frierson.   

Abstract

The clinicopathologic features of 21 olfactory neuroblastomas are reviewed with emphasis on variables of potential diagnostic or prognostic value. The patients ranged in age from 9 to 66 years (median: 49 years); 57% were women. At the time of diagnosis, one tumor was Kadish stage A, 11 were stage B, and nine were stage C. Nineteen patients had extensive surgical resections, but in six instances these were considered incomplete. Six patients (29%) developed local recurrences and eight (38%) had metastases. Ten patients (48%) were alive and free of disease from 10 to 239 months (median: 58 months) after diagnosis. Seven (33%) died of tumor, with a duration of survival ranging from 1 to 142 months (median: 27 months). A fibrillary intercytoplasmic back-ground was the most useful diagnostic feature microscopically and was present, at least focally, in 18 of 21 tumors. A silver stain for neuronal processes was helpful when fibrils could not be seen on hematoxylin- and eosin-stained sections. Homer-Wright rosettes, when present, also aided in diagnosis but were well formed in only six tumors. The only clinical feature that correlated with prognosis was whether the neoplasm had been completely excised at initial presentation. Tumor necrosis was the only histologic feature correlating with prognosis, but neither association was statistically significant. Metastases, clinical stage, mitotic rate, and nuclear pleomorphism showed no relationship to survival in this series.

Entities:  

Mesh:

Year:  1985        PMID: 4091174

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

1.  Ectopic olfactory neuroblastoma: report of four cases and a review of the literature.

Authors:  R Wormald; P Lennon; T P O'Dwyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-16       Impact factor: 2.503

2.  Esthesioneuroblastoma: a nasal catecholamine-producing tumor of neural crest origin. Demonstration of tyrosine hydroxylase-immunoreactive tumor cells.

Authors:  H Takahashi; K Wakabayashi; F Ikuta; K Tanimura
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 3.  Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

4.  Aesthesioneuroblastoma of Nose.

Authors:  S C Gupta; A K Das; M D Venkatesh; R C Kashyap; S Bhattacharya
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 5.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Ganglioneuroblastic transformation in olfactory neuroblastoma.

Authors:  Timothy Bates; Daniel Du Plessis; Tuomo Polvikoski; Philip Sloan; Andrew McQueen; David Meikle; Charles Kelly; Max Robinson
Journal:  Head Neck Pathol       Date:  2011-09-14

Review 7.  The small round blue cell tumors of the sinonasal area.

Authors:  Julia A Bridge; Joslin M Bowen; Russell B Smith
Journal:  Head Neck Pathol       Date:  2010-01-26

8.  Intracranial olfactory neuroblastoma: evidence for olfactory epithelial origin.

Authors:  A K Banerjee; B S Sharma; R K Vashista; V K Kak
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

9.  Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).

Authors:  M E Carney; R C O'Reilly; B Sholevar; O I Buiakova; L D Lowry; W M Keane; F L Margolis; J L Rothstein
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

10.  Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma.

Authors:  P H Sorensen; J K Wu; K W Berean; J F Lim; W Donn; H F Frierson; C P Reynolds; D López-Terrada; T J Triche
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.